Showing results (151-160 of 208) with videos related to

Sort By:
Pageof 21
Cancer Research|June 3, 2006
Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cellsPhillip H Abbosh, John S Montgomery, Jason A Starkey, et al.
Nucleic Acids Research|January 16, 2014
Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancerDayong Wu, Benjamin Sunkel, Zhong Chen, et al.
Non-Coding RNA|April 17, 2018
Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform VariationAdrienne K Conger, Elizabeth C Martin, Thomas J Yan, et al.
Cancer Research|November 19, 2004
Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancerYu-Wei Leu, Pearlly S Yan, Meiyun Fan, et al.
Cancer Medicine|November 2, 2020
A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancerCostantine Albany, Zeeshan Fazal, Ratnakar Singh, et al.
The Journal of Urology|November 22, 2011
Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug developmentNoah M Hahn, Patty L Bonney, Deepika Dhawan, et al.
Molecular Cell|February 4, 2006
Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promotersAlfred S L Cheng, Victor X Jin, Meiyun Fan, et al.
Gynecologic Oncology|March 11, 2023
Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivorsKathryn Osann, Lari Wenzel, Chelsea McKinney, et al.
Clinical Epigenetics|February 10, 2022
Aberrant epigenetic and transcriptional events associated with breast cancer riskNatascia Marino, Rana German, Ram Podicheti, et al.
Neoplasia (New York, N.Y.)|August 21, 2008
Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancerMichael Wy Chan, Yi-Wen Huang, Corinna Hartman-Frey, et al.
Pageof 21